These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases. Eng CM; Desnick RJ Adv Genet; 2001; 44():275-96. PubMed ID: 11596990 [TBL] [Abstract][Full Text] [Related]
26. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Roa BB; Boyd AA; Volcik K; Richards CS Nat Genet; 1996 Oct; 14(2):185-7. PubMed ID: 8841191 [TBL] [Abstract][Full Text] [Related]
27. Response to ACMG guideline: carrier screening in individuals of Ashkenazi Jewish decent. Levy-Lahad E; Zuckerman S; Sagi M Genet Med; 2008 Jun; 10(6):462; author reply 463. PubMed ID: 18496217 [No Abstract] [Full Text] [Related]
28. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Oddoux C; Struewing JP; Clayton CM; Neuhausen S; Brody LC; Kaback M; Haas B; Norton L; Borgen P; Jhanwar S; Goldgar D; Ostrer H; Offit K Nat Genet; 1996 Oct; 14(2):188-90. PubMed ID: 8841192 [TBL] [Abstract][Full Text] [Related]
29. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population. Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474 [TBL] [Abstract][Full Text] [Related]
30. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population. Whitney MA; Jakobs P; Kaback M; Moses RE; Grompe M Hum Mutat; 1994; 3(4):339-41. PubMed ID: 8081385 [TBL] [Abstract][Full Text] [Related]
32. High frequency of a common Bloom syndrome Ashkenazi mutation among Jews of Polish origin. Shahrabani-Gargir L; Shomrat R; Yaron Y; Orr-Urtreger A; Groden J; Legum C Genet Test; 1998; 2(4):293-6. PubMed ID: 10464606 [TBL] [Abstract][Full Text] [Related]
33. Molecular screening for diseases frequent in Ashkenazi Jews: lessons learned from more than 100,000 tests performed in a commercial laboratory. Strom CM; Crossley B; Redman JB; Quan F; Buller A; McGinniss MJ; Sun W Genet Med; 2004; 6(3):145-52. PubMed ID: 15354333 [TBL] [Abstract][Full Text] [Related]
34. Some genetics for some Jews: a Jewish look at the human genome. Pollack R Conserv Jud; 2002; 54(3):3-12. PubMed ID: 12735297 [No Abstract] [Full Text] [Related]
35. The possibility of a selection process in the Ashkenazi Jewish population. Zlotogora J; Bach G Am J Hum Genet; 2003 Aug; 73(2):438-40; author reply 440-1. PubMed ID: 12868052 [No Abstract] [Full Text] [Related]
36. Human genetics. Jewish lysosomes. Diamond JM Nature; 1994 Mar; 368(6469):291-2. PubMed ID: 8127362 [No Abstract] [Full Text] [Related]
37. Technical validation of a multiplex platform to detect thirty mutations in eight genetic diseases prevalent in individuals of Ashkenazi Jewish descent. Strom CM; Janeczko RA; Anderson B; Redman J; Quan F; Buller A; McGinniss MJ; Sun WM Genet Med; 2005; 7(9):633-9. PubMed ID: 16301865 [TBL] [Abstract][Full Text] [Related]
38. Canavan disease: diagnosis and molecular analysis. Matalon R Genet Test; 1997; 1(1):21-5. PubMed ID: 10464621 [TBL] [Abstract][Full Text] [Related]
39. Rapid detection of the two common mutations in Ashkenazi Jewish patients with mucolipidosis type IV. Wang ZH; Zeng B; Pastores GM; Raksadawan N; Ong E; Kolodny EH Genet Test; 2001; 5(2):87-92. PubMed ID: 11551108 [TBL] [Abstract][Full Text] [Related]
40. Cystic fibrosis in Jews: frequency and mutation distribution. Kerem B; Chiba-Falek O; Kerem E Genet Test; 1997; 1(1):35-9. PubMed ID: 10464623 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]